https://doi.org/10.4081/gc.2020.9330
COVID-19 treatment in the older people: a brief clinical review
Accepted: 11 December 2020
HTML: 28
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
This paper summarizes the latest data about the treatment options available for coronavirus disease 2019 (COVID-19), paying special attention to the older patients. This review explored both trials that have included older patients and some clinically relevant drug-drug interactions. The data have been updated to 31st October, 2020. In particular, details have been reported about the use of antivirals, heparin, steroid and hyperimmune plasma.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Alberto Castagna, Francesco Vetta, Giuseppe Attisani, Raffaele Costa, Carmen Ruberto, Viviana Vespertini, Lucio Cosco, Giovanni Ruotolo, Hydroxychloroquine and QTc: beyond COVID-19 , Geriatric Care: Vol. 6 No. 3 (2020)
You may also start an advanced similarity search for this article.